DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

Summary

This is a pilot, phase 2, prospective, comparative study to evaluate the safety and efficacy of the combination of Levulan® Kerastick® for Topical Solution and blue light illumination using the BLU-U® Blue Light Photodynamic Therapy Illuminator (LevulanPDT). The study hypothesis is that post solid organ transplantation patients, highly susceptible to non-melanoma skin cancer, can be treated safely and effectively through clinical cyclic application of PDT, lessening morbidity and possible mortality for this immunosuppressed patient population.

Timeline

Start

2017-08-29

Primary completion

2024-02-20

Completion

2024-02-20

Drugs

Indications